Novartis

Director, Atherosclerotic Cardiovascular Disease (ASCVD)

Basel (City) Full time

Job Description Summary

The International Value & Access (V&A) Director, ASCVD, is responsible for co-developing innovative and winning market access strategies, optimizing the payer value proposition and access-relevant evidence packages for Atherosclerotic Cardiovascular Disease (ASCVD) asset(s).
The Director will develop and implement transformative access solutions supporting the ASCVD disease area, maximizing the value of ASCVD assets across priority geographic markets (CN, DE, JP), major HTA archetypes (e.g., UK/CAN), and Budget Impact archetypes (e.g., Italy/Spain).

The Director will also ensure timely and high-quality access inputs into Integrated Evidence Plans (IEPs), Integrated Product Strategies (IPS), and asset maximization efforts, fostering collaboration internally and externally to drive innovation and shape the future of ASCVD care. The role may require that launch/in-line asset payer evidence requirements and access needs are shared in follow-on, pipeline asset Target Product Profiles (TPPs), clinical development plans, and integrated product strategies.


 

Job Description

Key Responsibilities:

  • Develop and operationalize the Integrated Product Access Strategy (IPAS) for ASCVD asset(s), creating and championing a compelling and competitive international strategic vision to enable successful access and reimbursement across key markets.
  • Collaborate across cross-functional partners (TA, Pricing, HEOR, PCO, Development, and Commercial) to ensure ASCVD asset differentiation is clearly defined, and evidence packages meet payer, patient, and healthcare system expectations.
  • Ensure that at launch, ASCVD asset(s) are supported by a robust payer value proposition—including a clear “value for money” story, a strong evidence package, and a pricing strategy maximizing both brand value and patient access.
  • Guide the development of HEOR deliverables (e.g., cost-effectiveness models, budget impact models, real-world evidence plans, and quality-of-life studies) to support international and local access needs.
  • Collaborate with the HEOR & Pricing teams to integrate evidence and pricing considerations into the access strategy, ensuring relevance to priority markets.
  • Define payer evidence requirements and anticipate access opportunities and risks in key Tier 1 and Top 11 markets.Develop and provide a comprehensive “access toolbox” to guide local market access activities, pricing submissions, and payer negotiations.
  • Partner with Clinical and Development teams to ensure access considerations are embedded in ASCVD asset later-stage clinical program, indication sequencing, and life-cycle management.
  • Stay abreast of internal and external developments, health policy trends, and payer expectations in major HTA and budget impact archetypes to anticipate market evolution and inform strategic decisions.
  • Collaborate with internal policy and development functions to ensure consistent, access-optimal approaches to shaping ASCVD asset’s value story and evidence generation.Disseminate ASCVD asset’s health system value and patient benefit through international fora, publications, and policy partnerships where appropriate.
  • Lead and manage the International Access community, ensuring collaboration, knowledge sharing, and strategic alignment across regions and countries.

Essential requirements:

  • 5+ years of experience in market access, pricing, or HEOR roles within the pharmaceutical industry.
  • 2+ years of international or ex-US regional experience.
  • Experience working early in the drug development lifecycle and integrating access needs into development plans.
  • Proven product launch experience, ideally in a cardiovascular or metabolic therapeutic area.
  • Demonstrated ability to influence and collaborate across cross-functional, matrixed organizations.
  • Expertise in access, pricing, or HEOR strategy development and execution.

Desirable requirements:

  • Advanced degree (MBA, Ph.D., M.D., Pharm.D., or M.Sc. in Health Economics or related field). Experience in cardiovascular or chronic disease therapeutic areas.
  • 7+ years of experience in market access or related functions. 5+ years of international or ex-US experience; ex-US country launch experience strongly preferred.

Location: This role is based in Basel, Switzerland
Benefits: Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: Novartis Life Handbook

Commitment to Diversity & Inclusion: Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.

Accessibility and accommodation: Novartis is committed to working with and providing reasonable accommodation to all individuals. If, be-cause of a medical condition or disability, you need a reasonable accommodation for any part of the recruitment process, or in order to receive more detailed information about the essential functions of a position, please send an e-mail to inclusion.switzerland@novartis.com and let us know the nature of your request and your contact information. Please include the job requisition number in your message.


 

Skills Desired

Access And Reimbursement Strategy, Access And Reimbursement Strategy, Agility, Analytical Skill, Analytical Thinking, Cross-Functional Collaboration, Customer-Centric Mindset, Employee Development, Finance, Go-To-Market Strategy, Healthcare Sector Understanding, Health Economics, Health Policy, Health Technology Assessment (HTA), Influencing Skills, Innovation, Inspirational Leadership, Lcm Strategy, Market Access Strategy, Negotiation Skills, People Management, Pricing Strategy, Process Management, Product Launches, Public Affairs {+ 7 more}